Prostate Cancer
Reviews

Volume 7 Number 2
February 2019

Home > Disciplines > Publications > Prostate Cancer Reviews > Volume 7, Year 2019 > Number 2, February

CONTENTS

▼

DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT

DIAGNOSIS

▲

.

Boehm K, Thomas C, Tsaur I.
[Genetic profiling in the diagnosis of hereditary prostate cancer: Where do we stand?]
Aktuelle Urol. 2018 Dec;49(6):525-529. doi: 10.1055/a-0755-7360. Epub 2018 Dec 6. German.
Source . Similar articles

.

Kweldam CF, van Leenders GJ, van der Kwast T.
Grading of prostate cancer: a work in progress.
Histopathology. 2019 Jan;74(1):146-160. doi: 10.1111/his.13767.
Source . Similar articles

.

Maurer T, Eiber M.
Practice changing for prostate cancer: a vision of the future.
Nat Rev Urol. 2018 Dec 13. doi: 10.1038/s41585-018-0134-6. [Epub ahead of print]
Source . Similar articles

.

Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RCN, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21.
Source . Similar articles

.

Padhani AR, Haider MA, Villers A, Barentsz JO.
Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: What We See and What We Miss.
Eur Urol. 2018 Dec 15. pii: S0302-2838(18)30963-1. doi: 10.1016/j.eururo.2018.12.004. [Epub ahead of print]
Source . Similar articles
Editorial relating to: Johnson DC et al, Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2018 Nov 30. pii: S0302-2838(18)30930-8. doi: 10.1016/j.eururo.2018.11.031. [Epub ahead of print]. Source .

.

Shetty D, Patel D, Le K, Bui C, Mansberg R.
Pitfalls in Gallium-68 PSMA PET/CT Interpretation-A Pictorial Review.
Tomography. 2018 Dec;4(4):182-193. doi: 10.18383/j.tom.2018.00021.
Source . Similar articles

EPIDEMIOLOGY, RISK FACTORS, PREVENTION

▲

.

Printz C.
Early-age drinkers more likely to have high-grade prostate cancer later.
Cancer. 2019 Jan 1;125(1):11. doi: 10.1002/cncr.31899.
Source . Similar articles

ETIOLOGY, PATHOGENESIS, PATHOLOGY

▲

.

Calzone KA et al, PDQ Cancer Genetics Editorial Board
Genetics of Prostate Cancer (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2018 Dec 18.
Source . Similar articles

.

Kucharczyk MJ, Gravis G, Niazi T.
The Biology of Oligometastatic Prostate Cancer: A Different Beast than Polymetastatic Prostate Cancer.
Eur Urol Focus. 2018 Dec 4. pii: S2405-4569(18)30372-9. doi: 10.1016/j.euf.2018.11.011.
Source . Similar articles

OVERALL MANAGEMENT

▲

.

Burstein HJ, Krilov L, Aragon-Ching JB, Baxter NN, Chiorean EG, Chow WA, De Groot JF, Devine SM, DuBois SG, El-Deiry WS, Epstein AS, Heymach J, Jones JA, Mayer DK, Miksad RA, Pennell NA, Sabel MS, Schilsky RL, Schuchter LM, Tung N, Winkfield KM, Wirth LJ, Dizon DS.
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
J Clin Oncol. 2017 Apr 20;35(12):1341-1367. doi: 10.1200/JCO.2016.71.5292. Epub 2017 Feb 1.
Source . Similar articles

.

Chaitoff A, Killeen TC, Nielsen C.
Men's health 2018: BPH, prostate cancer, erectile dysfunction, supplements.
Cleve Clin J Med. 2018 Nov;85(11):871-880. doi: 10.3949/ccjm.85a.18011. Review. Erratum .
Source . Similar articles

.

Heidelbaugh JJ.
The Adult Well-Male Examination.
Am Fam Physician. 2018 Dec 15;98(12):729-737.
Source . Similar articles

.

Heymach J, Krilov L, Alberg A, Baxter N, Chang SM, Corcoran R, Dale W, DeMichele A, Magid Diefenbach CS, Dreicer R, Epstein AS, Gillison ML, Graham DL, Jones J, Ko AH, Lopez AM, Maki RG, Rodriguez-Galindo C, Schilsky RL, Sznol M, Westin SN, Burstein H.
Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
J Clin Oncol. 2018 Apr 1;36(10):1020-1044. doi: 10.1200/JCO.2017.77.0446. Epub 2018 Jan 30.
Source . Similar articles

.

Morgan SC, Rumble RB, Sandler H.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline Summary.
J Oncol Pract. 2019 Jan;15(1):50-54. doi: 10.1200/JOP.18.00616. Epub 2018 Dec 4.
Source . Similar articles

.

Parikh RB, Prasad V.
Metastasis-Free Survival in Prostate Cancer: Faster Drug Approvals, Better Drugs?
J Clin Oncol. 2018 Dec 11:JCO1801092. doi: 10.1200/JCO.18.01092. [Epub ahead of print]
Source . Similar articles

.

Simmons MN, Berglund RK, Jones JS.
A practical guide to prostate cancer diagnosis and management.
Cleve Clin J Med. 2011 May;78(5):321-31. doi: 10.3949/ccjm.78a.10104.
Source . Similar articles

PROGNOSIS

▲

.

Matoso A, Epstein JI.
Defining clinically significant prostate cancer on the basis of pathological findings.
Histopathology. 2019 Jan;74(1):135-145. doi: 10.1111/his.13712.
Source . Similar articles

.

Mayor S.
Radical prostatectomy extends life expectancy in localised prostate cancer, trial finds.
BMJ. 2018 Dec 12;363:k5263. doi: 10.1136/bmj.k5263.
Source . Similar articles
Comment on: Bill-Axelson A et al, Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up. N Engl J Med. 2018 Dec 13;379(24):2319-2329. doi: 10.1056/NEJMoa1807801. Source .

.

Pinart M, Kunath F, Lieb V, Tsaur I, Wullich B, Schmidt S; German Prostate Cancer Consortium (DPKK).
Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review.
World J Urol. 2018 Dec 15. doi: 10.1007/s00345-018-2574-2. [Epub ahead of print]
Source . Similar articles

.

Sasaki T, Sugimura Y.
The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients.
J Clin Med. 2018 Dec 18;7(12). pii: E565. doi: 10.3390/jcm7120565.
Source . Similar articles

TREATMENT

▲

.

Albisinni S, Aoun F, Diamand R, Al-Hajj Obeid W, Porpiglia F, Roumeguere T, De Nunzio C.
Cytoreductive prostatectomy: what is the evidence? A systematic review.
Minerva Urol Nefrol. 2018 Dec 14. doi: 10.23736/S0393-2249.18.03319-2. [Epub ahead of print]
Source . Similar articles

.

Catton CN, Lukka H, Martin J.
Prostate Cancer Radiotherapy: An Evolving Paradigm.
J Clin Oncol. 2018 Oct 10;36(29):2909-2913. doi: 10.1200/JCO.2018.79.3257. Epub 2018 Aug 23.
Source . Similar articles

.

Cully M.
Anticancer drugs: Cutting down on prostate cancer metastases.
Nat Rev Drug Discov. 2018 Dec 28;18(1):17. doi: 10.1038/nrd.2018.225.
Source . Similar articles
Article review relating to: Rotinen M et al, ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat Med. 2018 Dec;24(12):1887-1898. doi: 10.1038/s41591-018-0241-1. Epub 2018 Nov 26. Source .

.

David J, Kamrava M.
Prostate Cancer Radiotherapy: An Evolving Paradigm That Should Also Include High-Dose-Rate Monotherapy.
J Clin Oncol. 2018 Dec 28:JCO1801482. doi: 10.1200/JCO.18.01482. [Epub ahead of print]
Source . Similar articles
Correspondence relating to: Catton CN et al, Prostate Cancer Radiotherapy: An Evolving Paradigm. J Clin Oncol. 2018 Oct 10;36(29):2909-2913. doi: 10.1200/JCO.2018.79.3257. Epub 2018 Aug 23. Source .

.

Di Lorenzo G, Buonerba C.
Oligometastatic Prostate Cancer: Is it Only a Matter of Perspective?
Eur Urol. 2018 Dec 24. pii: S0302-2838(18)30998-9. doi: 10.1016/j.eururo.2018.12.010. [Epub ahead of print]
Source . Similar articles

.

Foster CC, Weichselbaum RR, Pitroda SP. Foster CC, Weichselbaum RR, Pitroda SP.
Oligometastatic prostate cancer: Reality or figment of imagination?
Cancer. 2019 Feb 1;125(3):340-352. doi: 10.1002/cncr.31860. Epub 2018 Dec 6.
Source . Similar articles

.

Gnanapragasam VJ, Barrett T, Massie C, Pacey S, Warren A.
Using prognosis to guide early detection and treatment selection in non-metastatic prostate cancer.
BJU Int. 2018 Nov 30. doi: 10.1111/bju.14637. [Epub ahead of print]
Source . Similar articles

.

Hamid AA, Morris MJ, Davis ID.
Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons.
Eur Urol Focus. 2018 Dec 14. pii: S2405-4569(18)30374-2. doi: 10.1016/j.euf.2018.12.001. [Epub ahead of print]
Source . Similar articles

.

Hoge C, George A, Sidana A.
Partial gland therapy for prostate cancer.
Cancer. 2018 Dec 20. doi: 10.1002/cncr.31823. [Epub ahead of print]
Source . Similar articles
Comment on: King MT et al, Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer. Cancer. 2018 Sep 1;124(17):3528-3535. doi: 10.1002/cncr.31568. Epub 2018 Jul 5. Source .

.

King MT, Nguyen PL, D'Amico AV, Orio PF 3rd.
Reply to Partial gland therapy for prostate cancer.
Cancer. 2018 Dec 20. doi: 10.1002/cncr.31822. [Epub ahead of print]
Source . Similar articles
Comment on: Hoge C et al, Partial gland therapy for prostate cancer. Cancer. 2018 Dec 20. doi: 10.1002/cncr.31823. [Epub ahead of print]. Source .

.

Lee CH, Kantoff P.
Treatment of Metastatic Prostate Cancer in 2018.
JAMA Oncol. 2018 Dec 27. doi: 10.1001/jamaoncol.2018.5621. [Epub ahead of print]
Opinion
Source . Similar articles

.

Martin J, Lukka H, Catton C.
Reply to J. David et al.
J Clin Oncol. 2018 Dec 28:JCO1801718. doi: 10.1200/JCO.18.01718. [Epub ahead of print]
Source . Similar articles
Correspondence relating to: David J et al, Prostate Cancer Radiotherapy: An Evolving Paradigm That Should Also Include High-Dose-Rate Monotherapy. J Clin Oncol. 2018 Dec 28:JCO1801482. doi: 10.1200/JCO.18.01482. [Epub ahead of print]. Source .

.

Shah H, Vaishampayan U.
Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of Treatment.
Target Oncol. 2018 Dec;13(6):679-689. doi: 10.1007/s11523-018-0611-0. First Online: 07 December 2018
Source . Similar articles

.

Spence W.
Personalising Prostate Radiotherapy in the Era of Precision Medicine: A Review.
J Med Imaging Radiat Sci. 2018 Dec;49(4):376-382. doi: 10.1016/j.jmir.2018.01.002. Epub 2018 Mar 12.
Source . Similar articles

.

Taneja SS.
Re: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
J Urol. 2019 Jan;201(1):31. doi: 10.1097/01.ju.0000550155.71767.b1.
Source . Similar articles
Comment on: Hussain M, et al., Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. N Engl J Med. 2018 Jun 28;378(26):2465-2474. doi: 10.1056/NEJMoa1800536. Source .

bottom

▲